We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




DNA Tests for Bioterrorism Threats

By HospiMedica staff writers
Posted on 30 Jan 2002
Field-ready DNA test kits for the rapid detection of anthrax, plague, tularemia, and botulism have been developed by Cepheid (Sunnyvale, CA, USA) in collaboration with the US Army Research Institute of Infectious Diseases (USAMRIID).

The new tests combine DNA sequences identified and validated by USAMRIID for bioterrorism-threat detection with Cepheid's proprietary reagent formulations and freeze-dry processing for prolonged stability and ease of use. More...
Cepheid has delivered the test kits to USAMRIID. They will be made available to several other US government agencies for evaluation and validation on Cepheid's Smart Cycler line of laboratory and field-portable DNA detection systems. Unlike most DNA test kits, which degrade and become ineffective after a few hours without refrigeration, Cepheid's reagent formulations and processing produce tests that remain stable for many months at room temperature. Each kit contains all the chemicals and reagents required to perform a polymerase chain reaction (PCR)-based test pre-measured and freeze-dried in a single tube. Cepheid has also developed a platform called GeneXpert that will allow minimally skilled users to obtain PCR test results from a raw sample in 30 minutes, enabling time-critical DNA tests at the point of need.

"The formulations and manufacturing process we've established will be applied to a broad spectrum of applications beyond bio-threat detection, including agricultural, veterinary, environmental, and infectious-disease testing,” said Thomas Gutshall, CEO and chairman of Cepheid.




Related Links:
Cepheid

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Gold Member
Blood Gas Analyzer
i-Check200
Surgical System
Stealth AXiS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.